Singapore markets closed

Aadi Bioscience, Inc. (AADI)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
14.13+0.43 (+3.14%)
At close: 04:00PM EDT
14.52 +0.39 (+2.76%)
After hours: 05:50PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 296.97M
Enterprise value 180.00M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/sales (ttm)44.03
Price/book (mrq)2.73
Enterprise value/revenue 26.69
Enterprise value/EBITDA -1.34

Trading information

Stock price history

Beta (5Y monthly) N/A
52-week change 3-51.31%
S&P500 52-week change 3-16.62%
52-week high 332.50
52-week low 311.00
50-day moving average 313.17
200-day moving average 316.25

Share statistics

Avg vol (3-month) 3128.69k
Avg vol (10-day) 3123.82k
Shares outstanding 521.02M
Implied shares outstanding 6N/A
Float 815.77M
% held by insiders 113.51%
% held by institutions 172.12%
Shares short (14 Sept 2022) 4735.84k
Short ratio (14 Sept 2022) 45.93
Short % of float (14 Sept 2022) 45.10%
Short % of shares outstanding (14 Sept 2022) 43.50%
Shares short (prior month 14 Aug 2022) 4640.13k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 21:15
Last split date 326 Aug 2021

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2021
Most-recent quarter (mrq)29 Jun 2022

Profitability

Profit margin 0.00%
Operating margin (ttm)-853.32%

Management effectiveness

Return on assets (ttm)-50.59%
Return on equity (ttm)-302.60%

Income statement

Revenue (ttm)6.74M
Revenue per share (ttm)0.37
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)-18.55M
EBITDA -57.35M
Net income avi to common (ttm)-135.85M
Diluted EPS (ttm)-8.81
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)118.74M
Total cash per share (mrq)5.65
Total debt (mrq)1.77M
Total debt/equity (mrq)1.63
Current ratio (mrq)9.87
Book value per share (mrq)5.17

Cash flow statement

Operating cash flow (ttm)-59.94M
Levered free cash flow (ttm)-46.89M